Finance
BlossomHill Therapeutics shares fall in debut after IPO
Latigo Biotherapeutics and BlossomHill Therapeutics have provided more color for their respective initial public offerings as the companies look to join a Nasdaq newcomer class that’s shaping up to be the largest in yea…